Table 3.

Subgroup analyses of effect of respiratory disease and overall patient health on COVID-19 associated erectile dysfunction

Cohort	Number in COVID cohort with outcome (%)	Number in non-COVID cohort with outcome (%)	Unbalanced OR (95% CI)	Balanced OR (95% CI)
All COVID patients	998 (0.34%)	27,287 (0.24%)	1.43 (1.35–1.53) P < .0001	1.14 (1.04–1.25) P = .0039
COVID patients with serious respiratory disease	144 (0.33%)	27,287 (0.24%)	1.36 (1.15–1.60) P = .0002	1.02 (0.82–1.28) P = .7097
COVID patients without hypertension, diabetes, or obesity	235 (0.14%)	27,287 (0.24%)*	1.23 (1.08–1.41) P = .0014	1.32 (1.08–1.60) P = .0053

All outcomes assessed between 1 and 6 months after COVID-19 diagnosis.

^⁎Comparison made against cohort without hypertension, diabetes, or obesity.